JPT Peptide Technologies Launches The Human Proteome Peptide Catalog
JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog , the first and most comprehensive online resource for validated reference peptides in mass-spectrometry based proteomics.
The new repository provides fast access to >400.000 light & heavy proteotypic peptides covering essentially all proteins of the human body. Currently, a total of 19.840 proteins is matched by the peptide collection and confirmed by more than 10.000.000 validated spectra available through the database ProteomicsDB.
Holger Wenschuh, Managing Director of JPT, states: “Together with our partners within the ProteomeTools Project we have worked for several years towards the goal of translating the human proteome information into reagents and online tools to decipher the complexity of the human organism on the functional level”, adding: “We are extremely excited to make this repository available to the broad life science community enabling a completely new dimension of research and development using mass-spectrometry based proteomics approaches.”
The Human Proteome Peptide Catalog is an interactive knowledge, spectra and peptide resource that will be continuously expanded with the support of JPT’s partners at the Technical University of Munich to also address a broad level of post-translational modifications, splice-variants, mutations and more.
JPT Peptide Technologies GmbH , a wholly owned subsidiary of BioNTech AG, is an DIN ISO 9001:2015 certified research and development partner and innovative service provider for peptide related projects in immunotherapy, proteomics and drug discovery. JPT’s key technologies SPOTTM – for ultra-high-throughput peptide synthesis and screening, PepStarTM – for high-content peptide microarrays, PepTrackTM - for flexible peptide library assembly, PepMixTM – for antigen specific T-cell stimulation using peptide pools, and SpikeTidesTM /SpikeMixTM – for protein biomarker discovery and quantification accelerate research and development in areas such as cell and immunotherapy, vaccine development, biomarker discovery, peptide lead identification and optimization, and proteomics. For more information, please visit www.jpt.com.
JPT Peptide Technologies
Dr. Holger Wenschuh
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
EGON-ZEHNDER/MOBIUS20.9.2018 08:03 | pressemeddelelse
Egon Zehnder and Mobius Executive Leadership Formalize Exclusive Strategic Partnership
TWISPAY20.9.2018 08:02 | pressemeddelelse
Twispay Teams up with Blue Air to Expand Digital Payments
ALIBABA-GROUP20.9.2018 06:02 | pressemeddelelse
Alibaba A.I. Labs Launches Hospitality Robot
CELLTRION20.9.2018 04:05 | pressemeddelelse
Celltrion Signs 'Incubation' Agreement with Emory University for Development of New Drugs for Atherosclerosis
NV-RIMINI-STREET,-INC.20.9.2018 01:02 | pressemeddelelse
Rimini Street Obtains Australian Single Touch Payroll Certification
CT-BATTEA-GLOBAL-LITIGAT20.9.2018 00:36 | pressemeddelelse
Litigation Researchers Believe - Dutch Court Ruling - Big Blow to Petrobras’ Arbitration Strategy
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum